Juan J. Picazo

Mexican Social Security Institute — Mexico

Medicine · Health Sciences

39h-index5.6kcitations190works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Antimicrobial Resistance in Staphylococcus(45), Bacterial Identification and Susceptibility Testing(44), Pneumonia and Respiratory Infections(41), Antibiotic Resistance in Bacteria(39), Antibiotics Pharmacokinetics and Efficacy(23)

Publications188 total

Índice de Angina Renal como Predictor de Lesión Renal Aguda en Urgencias
Ciencia Latina Revista Científica Multidisciplinar·2025Open Access
Comparison of performance of MALDI-TOF MS and MLST for biotyping carbapenemase-producing Klebsiella pneumoniae sequence types ST11 and ST101 isolates
Enfermedades infecciosas y microbiologia clinica (English ed )·2022· 2 cited
Vaccine against COVID-19
Revista Española de Quimioterapia·2021· 17 citedOpen Access
Comparison of performance of MALDI-TOF MS and MLST for biotyping carbapenemase-producing Klebsiella pneumoniae sequence types ST11 and ST101 isolates
Enfermedades Infecciosas y Microbiología Clínica·2020· 8 cited
Impact of 13-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in children under 15 years old in Madrid, Spain, 2007 to 2016: The HERACLES clinical surveillance study
Vaccine·2019· 30 cited
Effects of 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease in Infants Aged 0 to 90 Days in Madrid, Spain
Journal of the Pediatric Infectious Diseases Society·2017· 4 citedOpen Access
Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis in children
Vaccine·2017· 26 cited
In-vitro activity of several antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA) isolates expressing aminoglycoside-modifying enzymes: potency of plazomicin alone and in combination with other agents
International Journal of Antimicrobial Agents·2017· 32 cited
Characterization and circulation of seasonal influenza viruses in Madrid, 2010‐2016
Journal of Medical Virology·2017· 12 cited
Effect of the different 13-valent pneumococcal conjugate vaccination uptakes on the invasive pneumococcal disease in children: Analysis of a hospital-based and population-based surveillance study in Madrid, Spain, 2007-2015
PLoS ONE·2017· 33 citedOpen Access
Plazomicin Activity against 346 Extended-Spectrum-β-Lactamase/AmpC-Producing Escherichia coli Urinary Isolates in Relation to Aminoglycoside-Modifying Enzymes
Antimicrobial Agents and Chemotherapy·2016· 27 citedOpen Access
Detection of Escherichia coli ST131 clonal complex (ST705) and Klebsiella pneumoniae ST15 among faecal carriage of extended-spectrum β-lactamase- and carbapenemase-producing Enterobacteriaceae
Journal of Medical Microbiology·2016· 27 cited
Evaluation of the Alere i Influenza A&B assay for rapid identification of influenza A and influenza B viruses
Journal of Medical Microbiology·2016· 18 cited
In vitro activity of the next-generation aminoglycoside plazomicin alone and in combination with colistin, meropenem, fosfomycin or tigecycline against carbapenemase-producing Enterobacteriaceae strains
International Journal of Antimicrobial Agents·2015· 58 cited
El desarrollo de nuevas vacunas
Enfermedades Infecciosas y Microbiología Clínica·2015· 15 cited
Could ceftaroline be an alternative therapy for linezolid resistant Staphylococcus epidermidis infections in Intensive Care Medicine?
PubMed·2015· 2 cited
Can Plazomicin Alone or in Combination Be a Therapeutic Option against Carbapenem-Resistant Acinetobacter baumannii?
Antimicrobial Agents and Chemotherapy·2015· 62 citedOpen Access
Characterization of Inhibitor-Resistant TEM β-Lactamases and Mechanisms of Fluoroquinolone Resistance in <i>Escherichia coli</i> Isolates
Microbial Drug Resistance·2015· 12 cited
The intangible benefits of vaccination – what is the true economic value of vaccination?
Journal of Market Access & Health Policy·2015· 26 citedOpen Access
Comparison of NITAG policies and working processes in selected developed countries
Vaccine·2014· 44 citedOpen Access
page 1 of 10Next →

Frequent Co-authors

Iciar Rodríguez-Avial(14), Esther Culebras(13), Carmen Betriú(12), Marı́a Gómez(7), Francisco Javier Candel(5), Carmen Rodríguez-Avial(5), Jesús Ruíz-Contreras(4), Juan Casado‐Flores(4), Teresa Hernández‐Sampelayo(4), Enrique Otheo(4), Cristina Méndez(4), Margarita Rubio Alonso(3), J Romero-Vivas(3), Gracia Morales(3), Elvira Baos(3), Maria F. Gomez(3), Roberto Álvarez‐Lafuente(3), Irene Peña(3), Paloma Merino(3), Fernando González‐Romo(3)